TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

6.62
Delayed Data
As of May 27
 +0.38 / +6.09%
Today’s Change
3.44
Today|||52-Week Range
7.49
+48.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-12.9M-35.1M-28.4M-54.2M
 
 
 
 
 
Depreciation54.8K56.3K58.1K52.5K
 
 
 
 
 
Total Other Cash Flow7.7M20.9M5.7M5.2M
 
 
 
 
 
Funds From Operations-5.2M-14.1M-22.7M-48.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-240.2K-1.4M-1.9M-3.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-5.0M-12.7M-20.8M-45.5M
 
 
 
 
 
 
InvestingCapital Expenditures-28.8K-66.4K-40.8K-31.0K
 
 
 
 
 
Other Investing - Uses0.000.00-103.7K10.7K
 
 
 
Net Cash Flow Investing-37.6K-272.5K-583.6K-606.8K
 
 
 
 
 
 
FinancingShort Term Borrowings3.0M6.4M0.000.00
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.00-4.7M0.00
 
 
Net Proceeds Stock Sale1.0M8.1M78.7M43.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing707.0K0.000.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing4.7M14.4M74.0M43.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash-296.5K1.4M52.6M-2.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account